CYP2A13 Polyclonal Antibody, Cy5 Conjugated
Product Specifications
Background
Exhibits a coumarin 7-hydroxylase activity. Active in the metabolic activation of hexamethylphosphoramide, N, N-dimethylaniline, 2'-methoxyacetophenone, N-nitrosomethylphenylamine, and the tobacco-specific carcinogen, 4- (methylnitrosamino) -1- (3-pyridyl) -1-butanone. Possesses phenacetin O-deethylation activity.
Synonyms
Cytochrome P450 2A13; CYP2A13; CYPIIA13; CYP2A13
Gene ID
1553
Swiss Prot
Q16696
Cellular Locus
Cytoplasm
Host
Rabbit
Cross Reactivity
Human
Immunogen
301-400/494
Target
CYP2A13
Clonality
Polyclonal
Isotype
IgG
Conjugation
Cy5
Source
KLH conjugated synthetic peptide derived from human CYP2A13
Applications
WB, IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
625,650nm/670nm
Concentration
1µg/µl
Dilution
WB (1:300-5000), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
1553
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
033138-HRP 200 µL
CACNG8, NT (CACNG8, CACNG6, Voltage-dependent calcium channel gamma-8 subunit, Neuronal voltage-gated calcium channel gamma-8 subunit, Transmembrane AMPAR regulatory protein gamma-8) (Azide free) (HRP) discontinued
Ask
View Details